Terminated PHASE3 Interventional 2-arm
NCT01345474
Phase 3 Clinical Trial: D-methionine to Reduce Noise-Induced Hearing Loss (NIHL) (NIHL)
Sponsor: MetArmor
Conditions
Noise-Induced Hearing Loss
Interventions
D-methionine, oral liquid suspension Placebo Comparator
Updated 3 times since 2017 Last updated: Apr 27, 2011
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Terminated
This trial was terminated. No reason was provided.
A PHASE3 clinical study on Noise-Induced Hearing Loss, this trial is terminated or withdrawn. The trial is conducted by MetArmor and has accumulated 3 data snapshots since 2026. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
3 versions recorded-
Oct 2017 — Present [monthly]
Terminated PHASE3
Status: Recruiting → Terminated
-
Feb 2017 — Oct 2017 [monthly]
Recruiting PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- MetArmor
- United States Department of Defense
Data source: MetArmor
For direct contact, visit the study record on ClinicalTrials.gov .